Thrombosis News and Research

Latest Thrombosis News and Research

Results from study comparing safety and efficacy of drug-eluting stents and bare-metal stents

The Cardiovascular Research Foundation (CRF) announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published today in The New England Journal of Medicine.

6 May 2009

Elevated level of certain protein in urine linked to increased risk for blood clots

Preliminary research suggests that higher than normal levels of the protein albumin in urine is associated with an increased risk for blood clots in the deep veins of the legs or lungs (venous thromboembolism; VTE), according to a study in the May 6 issue of JAMA, the Journal of the American Medical Association.

5 May 2009

Urine proteome pattern may predict coronary artery disease

Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.

30 Apr 2009

Healthcare reform should start with paying evidence-based financial incentives to doctors

Healthcare Reform should start with "evidence-based reimbursement", structuring physician payment incentives around existing empirical evidence of clinical benefit, which would improve quality and reduce the cost of healthcare, says a commentary written by two cardiologists and published in Circulation: Cardiovascular Quality and Outcomes .

20 Apr 2009

Large safety gaps identified between top and bottom performing hospitals

The 2009 HealthGrades Patient Safety Excellence Award™ recipients were identified in a report issued today by the leading independent healthcare ratings organization.

8 Apr 2009

Moderate kidney disease associated with cardiovascular events

Chronic kidney disease patients face a greater risk of cardiovascular events such as stent thrombosis after being treated for heart attacks, even if their kidney disease is moderate, according to researchers from Wake Forest University Baptist Medical Center.

6 Apr 2009

Steroids and antihistamines alleviate clopidogrel-related allergic reaction symptoms

A clinical study of cardiac patients who suffered an allergic reaction to the widely-prescribed drug clopidogrel, also known by the pharmaceutical name Plavix, found that treatment with a combination of steroids and antihistamines can alleviate the allergic reaction symptoms thereby allowing patients to remain on the drug, say doctors from Thomas Jefferson University Hospital.

30 Mar 2009

Drug-coated stents lower risk of heart attack and death

Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.

30 Mar 2009

CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism

A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p=0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).

29 Mar 2009

Trial reinforces safety and efficacy of Boston Scientific's two drug-eluting stent platforms

Boston Scientific Corporation has welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of two-year data from the SPIRIT II and III Trials.

29 Mar 2009

Clinical effectiveness of coronary stents in the elderly

29 Mar 2009

Transdermal delivery of estrogen therapy may show safety benefits as opposed to oral delivery

Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests.

29 Mar 2009

Family history linked to increased risk of venous thrombosis

Children and siblings of those with venous thrombosis, or blood clots in the veins, appear to have more than double the risk of developing the condition than those without a family history, according to a report in the March 23 issue of Archives of Internal Medicine.

23 Mar 2009

Bioabsorbable stents show promise

A study published online in The Lancet presented two year data for the bioabsorbable everolimus coronary stent.

15 Mar 2009

Schering-Plough's investigational oral thrombin receptor antagonist meets primary endpoint in a newly published study

Results of a Schering-Plough Corporation Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary endpoints of safety and tolerability.

12 Mar 2009

Number of cardiovascular risk factors could determine safety of IVIg treatment

New research out of Wake Forest University School of Medicine identifies the presence of cardiovascular risk factors as an indicator of how likely it is that elderly, hospitalized patients who receive intravenous immunoglobulin (IVIg) treatment will have a stroke or heart attack.

5 Mar 2009

Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment

5 Mar 2009

Blood clots after hip and knee replacements

As the number of hip and knee replacements skyrocket into the coming years, patients and orthopaedic surgeons need to work together to evaluate and assess a potentially fatal complication - blood clots.

26 Feb 2009

European Society of Cardiology reaffirms advice on cardiovascular risks associated with long-haul flights

Following a review by The Lancet of the medical issues associated with commercial air travel, the European Society of Cardiology has reaffirmed its advice about the risks of venous thromboembolism (VTE), whose risk, according to The Lancet, is increased "up to four-fold" by long-haul flight.

24 Feb 2009

Fractures due to osteoporosis in seniors a signal for premature death

An Australian study has found that people over 60 years old who have had a fracture because of reduced bone density, or osteoporosis, face a higher risk of death over the next 5 to 10 years compared to the general population and those who experience additional fractures increase their risk of death further.

3 Feb 2009

Thrombosis News and Research

Latest Thrombosis News and Research

Results from study comparing safety and efficacy of drug-eluting stents and bare-metal stents

Elevated level of certain protein in urine linked to increased risk for blood clots

Urine proteome pattern may predict coronary artery disease

Healthcare reform should start with paying evidence-based financial incentives to doctors

Large safety gaps identified between top and bottom performing hospitals

Moderate kidney disease associated with cardiovascular events

Steroids and antihistamines alleviate clopidogrel-related allergic reaction symptoms

Drug-coated stents lower risk of heart attack and death

CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism

Trial reinforces safety and efficacy of Boston Scientific's two drug-eluting stent platforms

Clinical effectiveness of coronary stents in the elderly

Transdermal delivery of estrogen therapy may show safety benefits as opposed to oral delivery

Family history linked to increased risk of venous thrombosis

Bioabsorbable stents show promise

Schering-Plough's investigational oral thrombin receptor antagonist meets primary endpoint in a newly published study

Number of cardiovascular risk factors could determine safety of IVIg treatment

Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment

Blood clots after hip and knee replacements

European Society of Cardiology reaffirms advice on cardiovascular risks associated with long-haul flights

Fractures due to osteoporosis in seniors a signal for premature death

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Thrombosis News and Research

Latest Thrombosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in